Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xyrem in Schizophrenia and Associated Sleep Disturbances
NCT00594256Phase 2Completed
- Sponsor
- Nathan S. Kline Institute for Psychiatric Research
- Start
- May 2008
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sodium oxybate in schizophrenia, Insomnia, sponsored by Nathan S. Kline Institute for Psychiatric Research. Started May 2008; status: completed.
02
Drugs
sodium oxybate
03
Conditions
schizophreniaInsomnia
Beyond the preview
Go deeper on NCT00594256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00594256.